Corvia Medical, Inc.
@corviamedical
Followers
79
Following
39
Media
100
Statuses
162
Corvia Medical, Inc. is revolutionizing the treatment of heart failure (HF) with a novel transcatheter structural heart device.
Tewksbury, MA
Joined June 2018
Corvia is proud to support the @MedUnivSC #charlestonHFpEF Conference from July 19-21. Heart failure with preserved ejection fraction (#HFpEF) is a hot topic — join course director @LitwinSheldon & other esteemed faculty to discover why! #heartfailure #atrialshunt #cardiotwitter
0
0
3
#CSIFrankfurt2024 is here! Don't miss today's session on #Interatrialshunt therapy at 16:15 CEST. With two #atrialshunt randomized trials now complete, come hear @amin_polzin discuss why the #Corvia Atrial Shunt holds promise for #HFpEF patients! #cardiotwitter #structuralheart
0
1
1
#CSIFrankfurt2024 is almost here! Don't miss Wednesday's #Interatrialshunt Workshop where @amin_polzin from @UniklinikDUS will share lessons learned from REDUCE LAP-HF II & how these findings are being validated in #RESPONDERHF. #atrialshunt #HFpEF #cardiotwitter #heartfailure
0
0
3
Jimmy's story gives us confidence we are on the right path with our confirmatory trial #RESPONDERHF. Learn more at https://t.co/u7lE8N8TuO.
@LitwinSheldon #HFpEF #atrialshunt Caution: Investigational device, limited by US law to investigational use. https://t.co/Geb15N48Ty
postandcourier.com
Heart failure leaves millions in the U.S. and South Carolina unable to do much and hastens death. MUSC is studying whether a hole in the heart might help them.
0
0
0
Great interview with @HFpEF regarding the favorable long-term effects of an #atrialshunt observed in REDUCE LAP-HF II #heartfailure patients.
Interview with Sanjiv J. Shah, MD, author of "Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial" hosted by James E. Udelson, MD. @HFpEF
0
0
0
What is the long-term effect of an #atrialshunt? Recently published data in @JAMACardio by @RBPatelMD shows favorable effects of the Corvia Atrial Shunt on cardiac structure & function in #heartfailure patients. #HFpEF #cardiotwitter
https://t.co/wMGwBUNxtc
jamanetwork.com
This post hoc analysis of A Study to Evaluate the Corvia Medical Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF II) randomized clinical trial...
0
0
1
During #NationalNursesWeek, we extend our deepest appreciation to all the incredible #HeartFailure nurses. Your expertise, empathy, and dedication are instrumental in improving life for millions. Thank you for being the heartbeat of compassionate care. #NursesWeek2024 #Corvia
0
0
0
Happy #NationalNursesDay to all the dedicated heart failure nurses! Your unwavering commitment & compassion make a significant impact on the lives of #heartfailure patients. Your dedication makes all the difference. #NursesMakeTheDifference #GratefulHeart #NursesWeek2024 #Corvia
0
0
0
Corvia Highlights Importance of Patient Selection in RESPONDER-HF Atrial Shunt Trial | @corviamedical
citoday.com
April 12, 2024—Corvia Medical, Inc. announced that the recently presented data from the RELIEVE-HF trial support the evidence base for atrial sh
0
1
1
We continue to learn which #heartfailure patients may benefit most from #atrialshunt therapy. Recent RELIEVE-HF data reinforces the importance of patient selection and suggests we are on the right path with #RESPONDERHF to confirm optimal #HFpEF patients. https://t.co/IXJ4m6iofR
us.corviamedical.com
Second major trial for atrial shunt therapy demonstrates importance of patient selection TEWKSBURY, MA – April 12, 2024 – Corvia Medical, Inc, a company dedicated to transforming the treatment of...
0
0
3
It's the last day of #ACC24, but there's still time time to come learn about #atrialshunt therapy and which #HFpEF patients might from participating in the #RESPONDERHF trial. Come see us at booth 3338! #CardioTwitter #HeartFailure
0
0
0
Congratulations to @vijayswarup and the @ArizonaRhythm team for the great coverage of their REDUCE LAP-HF II patient and their ongoing work to bring #atrialshunt therapy to #heartfailure patients in AZ. https://t.co/3LFiheAIBj
#HFpEF #CardioTwitter #clinicaltrials #RESPONDERHF
fox10phoenix.com
A clinical trial is underway in the Valley to find a new treatment for a deadly form of heart failure. FOX 10's Dominique Newland has the details.
0
0
0
FACT: #HeartFailure affects 6.2 million people in the US—this may include someone you love. Join #Corvia this #HeartMonth to prioritize #hearthealth awareness. Your knowledge could change a life. Learn more about heart failure here: https://t.co/ZTgm8b6Pok
#twittercardio
us.corviamedical.com
Has heart failure impacted your quality of life? Learn about a novel, cardiac implant proven to reduce HF symptoms and improve your quality of life.
0
0
0
February is American #HeartMonth ❤️, a time to raise awareness about heart health and cardiovascular disease. #CorviaMedical is proud to be part of the solution to improve the lives of millions of people who suffer from heart disease. #HeartMonth2024 #cardiotwitter #corvia
0
0
0
As the year comes to a close, we want to take a moment to express our #gratitude to our investigators, customers, and partners for their support throughout the year. May this #holidayseason bring you love, light, and laughter, and the New Year bring much #prosperity & #success.
0
0
2
We hope to see you in Wiesbaden, Germany at #CSIFocusDHF! Thanks in advance to Prof. Rudin Pistulli who will present his experience with the #Corvia Atrial Shunt and to @CSIcongress for its continued focus on the potential of #atrialshunt therapy for #heartfailure. #CSIDHF
0
0
1
#Heartlive in Munich begins later this week! Hear from the experts - Profs. Ulf Landmesser, Martin Bergmann, and Mirjam Keßler - at our symposium on #atrialshunt therapy for #HFpEF. Stop by booth #13 and learn about our confirmatory trial #RESPONDERHF. #Corvia #heartfailure
0
0
1
Congratulations to @vikjag45 and the team at @WVUMedicine for leading the way and being the first center in West Virginia to enroll a patient in the #RESPONDERHF trial. Together, we are working to give #heartfailure patients another reason to hope. #HFpEF #atrialshunt
0
0
1
In “BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction”, @HFpEF shares imperfections in using NPs in #HFpEF. Corvia's #RESPONDERHF #atrialshunt trial includes these HFpEF pts with low NPs who might otherwise be overlooked. https://t.co/gW2iwHhX5S
academic.oup.com
This editorial refers to ‘Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased mo
0
0
1
#Heartfailure expert and PI for Corvia's RESPONDER-HF trial, @LitwinSheldon from @MedUnivSC describes the unmet need of #HFpEF and how #atrialshunt therapy, being evaluated through #RESPONDERHF, could be a game-changer for patients & clinicians. #clinicaltrials #CardioTwitter
A Lifesaving Shunt in the Heart? | By Dr. Sheldon Litwin "Approximately 60 study sites worldwide are participating in RESPONDER-HF, a randomized clinical trial of the Corvia Atrial Shunt." Read what this expert has to say.
0
0
0